Additionally, the analysis shows that IGFBP4 is a significant independent predictor, correlated with FSTL1 in the total population (p = 0.011) and in people with OSA (p = 0.005), suggesting a metabolic role in FSTL1 regulation. The gene discussed is IGFBP4; the disease is obstructive sleep apnea syndrome.